Bangladesh: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2022

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Bangladesh

In 2021, the Bangladeshi prophylactic medicaments containing insulin market increased by X% to $X, rising for the fourth consecutive year after two years of decline. Over the period under review, consumption, however, recorded a abrupt curtailment. Prophylactic medicaments containing insulin consumption peaked at $X in 2012; however, from 2013 to 2021, consumption failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Bangladesh

In 2021, after two years of growth, there was significant decline in overseas shipments of medicaments containing insulin but not antibiotics in measured doses, when their volume decreased by -X% to X kg. Over the period under review, exports saw a sharp decline. The most prominent rate of growth was recorded in 2019 with an increase of X%. The exports peaked at X tons in 2013; however, from 2014 to 2021, the exports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin exports expanded modestly to $X in 2021. In general, exports saw a precipitous slump. The pace of growth was the most pronounced in 2019 when exports increased by X% against the previous year. The exports peaked at $X in 2013; however, from 2014 to 2021, the exports stood at a somewhat lower figure.

Exports by Country

The Philippines (X kg) was the main destination for prophylactic medicaments containing insulin exports from Bangladesh, with a X% share of total exports. Moreover, prophylactic medicaments containing insulin exports to the Philippines exceeded the volume sent to the second major destination, Kenya (X kg), twofold. The third position in this ranking was occupied by Belize (X kg), with a X% share.

From 2012 to 2021, the average annual growth rate of volume to the Philippines amounted to +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Kenya (-X% per year) and Belize (-X% per year).

In value terms, El Salvador ($X), the Philippines ($X) and Kenya ($X) appeared to be the largest markets for prophylactic medicaments containing insulin exported from Bangladesh worldwide, with a combined X% share of total exports.

El Salvador, with a CAGR of X%, saw the highest rates of growth with regard to the value of exports, among the main countries of destination over the period under review, while shipments for the other leaders experienced a decline.

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2021, increasing by X% against the previous year. Overall, the export price, however, recorded a noticeable decrease. The pace of growth was the most pronounced in 2017 an increase of X%. The export price peaked at $X per ton in 2013; however, from 2014 to 2021, the export prices stood at a somewhat lower figure.

There were significant differences in the average prices for the major overseas markets. In 2021, the country with the highest price was El Salvador ($X per ton), while the average price for exports to Kenya ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to El Salvador (X%), while the prices for the other major destinations experienced a decline.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Bangladesh

In 2021, the amount of medicaments containing insulin but not antibiotics in measured doses imported into Bangladesh rose markedly to X tons, picking up by X% compared with the previous year's figure. Over the period under review, imports, however, continue to indicate a abrupt shrinkage. The most prominent rate of growth was recorded in 2015 when imports increased by X% against the previous year. Imports peaked at X tons in 2012; however, from 2013 to 2021, imports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin imports declined to $X in 2021. Overall, imports, however, showed a abrupt curtailment. The pace of growth appeared the most rapid in 2015 when imports increased by X% against the previous year. Over the period under review, imports attained the maximum at $X in 2012; however, from 2013 to 2021, imports stood at a somewhat lower figure.

Imports by Country

The United States (X tons), Denmark (X tons) and France (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Bangladesh, with a combined X% share of total imports.

From 2012 to 2021, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by the United States (with a CAGR of +X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, Denmark ($X) constituted the largest supplier of prophylactic medicaments containing insulin to Bangladesh, comprising X% of total imports. The second position in the ranking was occupied by the United States ($X), with a X% share of total imports. It was followed by France, with a X% share.

From 2012 to 2021, the average annual growth rate of value from Denmark stood at -X%. The remaining supplying countries recorded the following average annual rates of imports growth: the United States (+X% per year) and France (-X% per year).

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2021, falling by -X% against the previous year. Over the last nine-year period, it increased at an average annual rate of +X%. The pace of growth appeared the most rapid in 2014 when the average import price increased by X%. As a result, import price reached the peak level of $X per ton. From 2015 to 2021, the average import prices remained at a lower figure.

Prices varied noticeably by the country of origin: the country with the highest price was Denmark ($X per ton), while the price for India ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Denmark (+X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform